Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company.
Our shares are listed on the SIX Swiss Exchange (NWRN).
Our mission is to discover, develop and commercialise novel drugs to treat
diseases of the Central Nervous System (CNS) and pain.
November 24-26, 2014 - Frankfurt-am-Main - Germany
November 5, 2014 - Zürich, Switzerland
October 7-8, 2014 - Palace Hotel, San Francisco, CA - USA